On 31 March 2014
Medicamen Biotech has announced that a meeting of the Board of Directors of the Company will be held on 31 March 2014, inter alia, to consider the Preferential Allotment of Equity Shares & Warrants convertible into Equity Shares to the promoter group.Powered by Capital Market - Live News
